Proteomics joins major health study to target lung disease
Proteomics International announces it has joined forces with the Busselton Population Medical Research Institute (BPMRI) to target improved diagnosis and treatment of lung conditions such as asthma and chronic obstructive pulmonary disease (COPD).
